Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice
Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice
复制标题
DOI：
10.2337/diabetes.53.4.1096
复制
发表时间：
2004-04-01
期刊：
影响因子：
7.7
通讯作者：
Madeddu, P
中科院分区：
文献类型：
--
作者：
Emanueli, C;Graiani, G;Madeddu, P
糖尿病大血管和微血管疾病导致组织灌注不足。这种缺陷，加上未能产生足够的血管生成反应，可能解释了为什么糖尿病患者的血管闭塞情况变得更加严重。本研究调查了使用人组织激肽释放酶（hTK）进行预防性基因治疗是否可以保护糖尿病肢体免受随之而来的缺血的影响。在同侧股动脉手术闭塞前 2 周，将载体（盐水）或携带 hTK (Ad.hTK) 或荧光素酶 (Ad.Luc) 基因的腺病毒注射到链脲佐菌素诱导的 1 型糖尿病小鼠的左内收肌中。注射盐水的非糖尿病小鼠作为对照。在缺血诱导后两周内连续分析后肢血流恢复情况。在尸检中，对骨骼肌中的微血管密度以及内皮细胞增殖和凋亡进行了定量。我们发现注射盐水的1型糖尿病小鼠的肢体灌注恢复延迟是由于修复性新生血管形成不足和内皮细胞凋亡过度激活。相比之下，预防性 Ad.hTK 恢复了对缺血产生适当的新生血管反应的能力，抑制了细胞凋亡，并上调了内皮一氧化氮合酶的表达。最终，通过 Ad.hTK 纠正糖尿病内皮病变，可以实现适当的灌注恢复，如在非糖尿病小鼠中所见。这些发现揭示了治疗糖尿病并发症的新治疗选择。
Diabetes macro- and microvascular disease causes tissue hypoperfusion. This deficit, together with a failure to mount an adequate angiogenic response, might explain why vascular occlusion evolves more severely among diabetic patients. The present study investigated whether prophylactic gene therapy with human tissue kallikrein (hTK) may protect diabetic limbs from the consequences of supervening ischemia. Vehicle (saline) or an adenovirus carrying the gene for either hTK (Ad.hTK) or luciferase (Ad.Luc) was injected into left adductor muscles of streptozotocin-induced type 1 diabetic mice 2 weeks before operative occlusion of the ipsilateral femoral artery. Saline-injected nondiabetic mice served as controls. Hindlimb blood flow recovery was analyzed sequentially over the 2 weeks after ischemia induction. At necroscopy, microvessel density and endothelial cell proliferation and apoptosis were quantified in skeletal muscles. We found that limb perfusion recovery of saline-injected type 1 diabetic mice is delayed because of insufficient reparative neovascularization and excessive activation of endothelial cell apoptosis. By contrast, prophylactic Ad.hTK renewed the ability to mount an appropriate neovascularization response to ischemia, suppressed apoptosis, and upregulated endothelial nitric oxide synthase expression. Ultimately, correction of diabetic endotheliopathy by Ad.hTK allowed proper perfusion recovery as seen in nondiabetic mice. These discoveries disclose new therapeutic options for the treatment of diabetic complications.